We have injected lipopolysaccharide (LPS) into the nigrostriatal pathway of rats in order to address the role of inflammation in Parkinson's disease (PD). LPS induced a strong macrophage/microglial reaction in Substantia nigra (SN), with a characteristic clustering of macrophage cells around bloodvessels. The SN was far more sensitive than the striatum to the inflammatory stimulus. Moreover, only the dopaminergic neurons of the SN were affected, with no detectable damage to either the GABAergic or the serotoninergic neurons. The damage to the DA neurons in the SN was permanent, as observed 1 year postinjection. Unlike the direct death of dopaminergic neurons caused by agents as MPP ؉ or 6-OHDA, LPS seems to cause indirect death due to inflammatory reaction. Therefore, we suggest that the injection of a single dose of LPS within the SN is an interesting model for studying the selective effects of inflammatory reaction on dopaminergic system and also potentially useful for studying PD.
INTRODUCTION
The pathological hallmark of Parkinson's disease (PD) is a specific degeneration of dopaminergic neurons in the substantia nigra (SN). The cause of chronic nigral cell death in PD and its underlying mechanisms remain elusive. Exogenous agents, infection, inflammatory response, and selective oxidative stress in the SN have been suggested as the most probable causes of the dopaminergic degeneration in the SN (Jankovic, 1993) . The principal knowledge of this process is based on studies of the selective action of neurotoxic substances such as 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which have revealed possible molecular mechanisms that give rise to neuronal death.
Some cases of PD are associated to head trauma and encephalitis, suggesting an inflammatory component of this disease. This is supported by several works describing different kind of inflammatory features present in parkinsonian brains. So, many cases of PD are accompanied by general brain inflammation with a dramatic proliferation of reactive ameboid macrophages and microglia in the SN (McGeer et al., 1988a,b; Akiyama & McGeer, 1989) . Even more, activated microglial cells are predominantly localized in SN, as revealed by specific markers for activated microglia, near dying neurons (McGeer et al., 1988a) . At the same time in the SN of PD patients it has been described an increased density of glial cells expressing different pro-inflammatory cytokines as TNF-␣, IL-␤, and IFN-␥ (Boka et al., 1994; Hunot et al., 1999) .
The most common response of astrocytes to CNS injury and neuropathological conditions is the so called "reactive astrogliosis" that involve hypertrophy and, occasionally, cell proliferation (for review see, Hatten et al., 1991; Norton et al., 1992; Landis, 1994; Norenberg, 1994) . Astrocytic reaction has been reported after administration of dopaminergic neuro-1 First two authors contributed equally to this report.
